Paper6513613
Admission criteria for immunogerontological studies in man: the SENIEUR protocol.
Ligthart GJ and 7 others. Mech Ageing Dev, 1984. Cited by 693 papers, by iCite.
Cite this record
ConductScience Library. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Papers, record 6513613. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6513613
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aging | Major topic |
| Immunity | Major topic |
| Research Design | Major topic |
| Adult | |
| Aged | |
| Cardiovascular Diseases | |
| Humans | |
| Infections | |
| Inflammation | |
| Lymphoproliferative Disorders | |
| Neoplasms |
Source PubMed
Cited by134
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 693 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41998482 | Immunological impact of age and comorbidities: findings from the REALISM and SENIOR-HLA-DR cohorts. | Aging Clin Exp Res | 2026 | https://conductscience.org/library/papers/41998482 | PubMed |
| 41596683 | Zinc Supplementation Partially Reconstitutes Impaired Interferon-γ Production in the Elderly. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596683 | PubMed |
| 40867519 | Engineered Glibenclamide-Loaded Nanovectors Hamper Inflammasome Activation in an Ex Vivo Alzheimer's Disease Model-A Novel Potential Therapy for Neuroinflammation: A Pilot Study. | Biomolecules | 2025 | https://conductscience.org/library/papers/40867519 | PubMed |
| 39273401 | Telomere Length, HLA, and Longevity-Results from a Multicenter Study. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273401 | PubMed |
| 38954761 | An updated immunosenescence exploration in healthy Chinese donors: circular elevated PD-1 on T cell and increased Ki67 on CD8+ T cell towards aging. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38954761 | PubMed |
| 37446334 | Cytokines as Biomarkers for Evaluating Physical Exercise in Trained and Non-Trained Individuals: A Narrative Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446334 | PubMed |
| 37239970 | TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer's Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37239970 | PubMed |
| 36609345 | Immunosenescence and inflammaging in the aged horse. | Immun Ageing | 2023 | https://conductscience.org/library/papers/36609345 | PubMed |
| 36247200 | Healthy Ageing Reflected in Innate and Adaptive Immune Parameters. | Clin Interv Aging | 2022 | https://conductscience.org/library/papers/36247200 | PubMed |
| 36079732 | Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study. | Nutrients | 2022 | https://conductscience.org/library/papers/36079732 | PubMed |
| 36059504 | Investigating population-level immunosenescence: From bench to bedside. | Front Immunol | 2022 | https://conductscience.org/library/papers/36059504 | PubMed |
| 35587609 | Gender-dependent frequency of unconventional T cells in a healthy adult Caucasian population: A combinational study of invariant NKT cells, γδ T cells, and mucosa-associated invariant T cells. | J Leukoc Biol | 2022 | https://conductscience.org/library/papers/35587609 | PubMed |
| 35326467 | Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions. | Cells | 2022 | https://conductscience.org/library/papers/35326467 | PubMed |
| 35038082 | Age-dependent frequency of unconventional T cells in a healthy adult Caucasian population: a combinational study of invariant natural killer T cells, γδ T cells, and mucosa-associated invariant T cells. | Geroscience | 2022 | https://conductscience.org/library/papers/35038082 | PubMed |
| 34832969 | Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer's Disease. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34832969 | PubMed |
| 34470917 | Blood transfusion practices affect CD4+ CD25+ FOXP3+ regulatory T cells/T helper-17 cells and the clinical outcome of geriatric patients with hip fracture. | Aging (Albany NY) | 2021 | https://conductscience.org/library/papers/34470917 | PubMed |
| 34255838 | Are the Healthy Vulnerable? Cytomegalovirus Seropositivity in Healthy Adults Is Associated With Accelerated Epigenetic Age and Immune Dysregulation. | J Infect Dis | 2022 | https://conductscience.org/library/papers/34255838 | PubMed |
| 34212550 | The Effect of Age on T-Regulatory Cell Number and Function in Patients With Asthma. | Allergy Asthma Immunol Res | 2021 | https://conductscience.org/library/papers/34212550 | PubMed |
| 34052362 | Investigating whether a combination of higher CRP and depression is differentially associated with worse executive functioning in a cohort of 43,896 adults. | Brain Behav Immun | 2021 | https://conductscience.org/library/papers/34052362 | PubMed |
| 33543410 | Effect of Antihypertensive and Statin Medication Use on Muscle Performance in Community-Dwelling Older Adults Performing Strength Training. | Drugs Aging | 2021 | https://conductscience.org/library/papers/33543410 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6513613
GET https://conductscience.org/api/papers/v1/6513613/cited_by?page=2